Rani Therapeutics Stock Forum

$Rani Therapeutics (RANI.US)$
NEWS
Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024
Rani Therapeutics, a clinical-stage biotherapeutics company, will present clinical and preclinical data on their oral delivery platform, the RaniPill® capsule, at Digestive Disease Week 2024. The data will focus on the oral delivery of an Ustekinumab biosimilar, showcasing high bioavailability in health...

$Rani Therapeutics (RANI.US)$
NEWS
Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update
Rani Therapeutics reported positive topline results from a Phase 1 study for RT-111, an oral anti-Interleukin 12/23 antibody, and plans to initiate a Phase 2 clinical trial for RT-102 for osteoporosis treatment in 2024. The company's RaniPill HC is set for potential Phase 1 trials later in 2024. Financially, Rani Therapeutics had $39.6 million in cash, cash equivalents, and...

$Rani Therapeutics (RANI.US)$ weird how this stock has no chatter despite being up 100% steadinly over the course of a week

$Rani Therapeutics (RANI.US)$ going up 10

$Rani Therapeutics (RANI.US)$  👀👀👀

Gainers:
In reaction to earnings/guidance:
• $Payoneer Global (PAYO.US)$ +19.4%, $Toast (TOST.US)$ +13.1%, $PDF Solutions (PDFS.US)$ +7.7%, $Wheels Up Experience (UP.US)$ +7.1%, $LegalZoom (LZ.US)$ +6.5%, $Joby Aviation (JOBY.US)$ +3.6%, $indie Semiconductor (INDI.US)$ +2.9%, $Rocket Lab (RKLB.US)$ +2.4%, $Rivian Automotive (RIVN.US)$ +1.2%
Other news:
• $WeTrade Group (WETG.US)$ +47.8%(announces $50 million sales of monkeypox virus test kits to Par...